Literature DB >> 34491

The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.

T Yeo, M O Thorner, A Jones, P J Lowry, G M Besser.   

Abstract

The control of secretion of prolactin was studied using continuous perfusion of a column of isolated rat pituitary cells supported by Bio-Gel polyacrylamide beads. Prolactin secretion was inhibited repeatedly by dopamine and rapidly recovered in its absence. Maximum inhibition was achieved at 5 x 10(-7) M dopamine. Bromocriptine and lergotrile directly inhibited prolactin release from the pituitary cells. Bromocriptine had a longterm action in inhibiting secretion. The dopamine receptor blocking agent, metoclopramide, overcame the inhibitory effect of dopamine but had no effect on prolactin secretion in its absence.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 34491     DOI: 10.1111/j.1365-2265.1979.tb01357.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

2.  Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing's syndrome: in vivo and in vitro studies.

Authors:  M Boscaro; G Merola; N Sonino; A M Menegus; F Sartori; F Mantero
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

3.  Perifusion of isolated rat pancreatic acini: carbamylcholine-induced biphasic amylase release.

Authors:  M Nagai; H Oka
Journal:  Gastroenterol Jpn       Date:  1989-08

4.  The effects of ranitidine on pituitary hormone secretion in vitro.

Authors:  T Yeo; G Delitala; G M Besser; C R Edwards
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

Review 5.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

6.  The management of prolactin-secreting pituitary tumors.

Authors:  S R George; G N Burrow
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

7.  Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.

Authors:  G M Besser; G Delitala; A Grossman; W A Stubbs; T Yeo
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

9.  Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia.

Authors:  E Ciccarelli; E Mazza; E Ghigo; F Guidoni; A Barberis; F Massara; F Camanni
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

10.  Prolactin and male fertility: the long and short feedback regulation.

Authors:  M K Gill-Sharma
Journal:  Int J Endocrinol       Date:  2009       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.